Evaluating the Utility of a New Pathogenicity Predictor for Pediatric Cardiomyopathy
Back to course
Pdf Summary
Asset Subtitle
Presenting Author - Alyssa L. Rippert, MS; Co-Author - Sarah Trackman, MS CGC; Co-Author - Danielle Burstein, MD; Co-Author - J. William Gaynor, MD; Co-Author - Heather Griffis, PhD; Co-Author - Christine Seymour, MS, CGC; Co-Author - Rebecca C. Ahrens-Nicklas, MD, PhD;
Meta Tag
Cardiac/circulatory disorders
Cardiovascular System
Genetic Testing
Genotype-Phenotype Correlations
Risk Assessment
Co-Author Sarah Trackman, MS CGC
Co-Author Danielle Burstein, MD
Co-Author J. William Gaynor, MD
Co-Author Heather Griffis, PhD
Co-Author Christine Seymour, MS, CGC
Co-Author Rebecca C. Ahrens-Nicklas, MD, PhD
Presenting Author Alyssa L. Rippert, MS
Keywords
retrospective cohort study
pediatric cardiomyopathy
CardioBoost scores
clinical outcomes
dilated cardiomyopathy
hypertrophic cardiomyopathy
major adverse cardiac events
adult and pediatric CM
variant interpretation
lead authors

© 2025 American College of Medical Genetics and Genomics. All rights reserved.

Powered By